Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1341745A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage
09/10/2003EP1341565A2 Drug delivery compositions and coated medical devices
09/10/2003EP1341555A2 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
09/10/2003EP1341549A2 Combination therapy for estrogen-dependent disorders
09/10/2003EP1341548A2 METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY $g(b)-AMYLOID PEPTIDES
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341544A1 Blocking the adsorption of germs in birds
09/10/2003EP1341543A2 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
09/10/2003EP1341542A2 Organic compounds
09/10/2003EP1341541A1 Combination therapy for lowering and controlling intraocular pressure
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341538A2 Novel medicament compositions
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341536A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
09/10/2003EP1341535A2 Skin whiteners containing hydroxytetronic acid
09/10/2003EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/10/2003EP1341532A2 Use of pyridoxamine for the treatment and inhibition of obesity-related complications
09/10/2003EP1341531A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
09/10/2003EP1341530A1 Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by dopaminergic means
09/10/2003EP1341529A2 Hydrolytically unstable compositions
09/10/2003EP1341528A1 Rapidly disintegrating tablet comprising an acid-labile active ingredient
09/10/2003EP1341527A1 Pharmaceutical preparation comprising an active dispersed on a matrix
09/10/2003EP1341524A2 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
09/10/2003EP1341523A1 Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
09/10/2003EP1341521A2 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
09/10/2003EP1341520A2 Antibiotic/benzoyl peroxide dispenser
09/10/2003EP1341518A2 Cosmetic and/or pharmaceutical emulsions
09/10/2003EP1341517A1 A skin cream composition
09/10/2003EP1341515A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same
09/10/2003EP1341512A1 Rhinological agents
09/10/2003EP1341500A1 Antifungal nail composition and method of use
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1341476A2 Intrasvascular drug delivery device and use therefor
09/10/2003EP1341467A2 Method for precipitating red blood cells
09/10/2003EP1341412A1 Indolocarbazole anticancer agents and methods of using them
09/10/2003EP1312373A8 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP1259513B1 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
09/10/2003EP1248601B1 Control of microbial populations in the gastrointestinal tract of animals
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP1169044B1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/10/2003EP1165136B1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
09/10/2003EP1156814B1 Pharmaceuticals, dietary supplements and cosmetic compositions comprising a fatty acid and ginger
09/10/2003EP1150657B1 SPRAY CONTAINING UBIQUINONE Qn
09/10/2003EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
09/10/2003EP1137644B1 Benzofuran derivatives, their preparation and use
09/10/2003EP1135389B1 1,4-diazabicyclo 3.2.2]nonane derivatives, their preparation and therapeutic application
09/10/2003EP1135139B1 Micronized eplerenone compositions
09/10/2003EP1131321B1 Indole derivatives and their use as serotonin receptor ligands
09/10/2003EP1127871B1 New esters derived from substituted phenyl-cyclohexyl compounds
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1107813A4 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
09/10/2003EP1094813B1 Use of piperine and derivatives thereof for treating skin pigmentation disorders and skin cancer
09/10/2003EP1091948B9 Tubulin binding compounds (cobra)
09/10/2003EP1090023B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1090021B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1082300B1 3-[(1'-n-methylamino)ethyl-n-benzyl]pyrrolidine monomethanesulfonate
09/10/2003EP1037633B1 Antiviral compounds
09/10/2003EP1035835B1 Long acting injectable formulations containing hydrogenated castor oil
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0998465B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
09/10/2003EP0996454B1 Use of polyallylamine polymers for the manufacture of a medicament for treating hypercholesterolemia
09/10/2003EP0991650B1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003EP0984938B1 Cyanoguanidines as cell proliferation inhibitors
09/10/2003EP0977553B1 Throat soothing compositions
09/10/2003EP0973501B1 Aqueous suspension for nasal administration of loteprednol
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0936906B1 Reflux inhibitors
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0921806B1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
09/10/2003EP0921804B1 Biphasic oral contraceptive method and kit comprising a combination of a progestin and estrogen
09/10/2003EP0914091B1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0906122B1 Activated linkers and methods for making and purifying the same
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0885237B1 Oligonucleotide analogues
09/10/2003EP0874822B1 New manufacturing process
09/10/2003EP0873341B1 Epothilone derivatives, preparation and use
09/10/2003EP0873139B1 Biotinylated antibodies with reduced net positive charge and toxin, drug or chelate
09/10/2003EP0851862B1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders
09/10/2003EP0835112B1 Medicament preparations containing tumour-inhibiting ruthenium (iii) complexes
09/10/2003EP0808317B1 Thienopyrimidine derivatives, their production and use
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003EP0772396B1 Method of regulating immune function
09/10/2003EP0769951B1 Long-acting oxytetracycline composition
09/10/2003EP0747389B1 3'-substituted nucleoside derivatives
09/10/2003EP0737067B1 Treatment of hormone-unresponsive metastatic prostate cancer
09/10/2003CN1441841A Stimulation of cellular regeneration and differentiation in inner ear
09/10/2003CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
09/10/2003CN1441805A Antitumoral analogue of Et-743
09/10/2003CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
1 ... 5348 5349 5350 5351 5352 5353 5354 5355 5356 5357 5358 5359 5360 5361 5362 5363 5364 5365 5366 5367 5368 ... 7860